Our Governance


idsMED is committed to the principles of good corporate governance which emphasize transparency, accountability and independence, and believe this enhances shareholder value.

We are committed to the principles of good corporate governance which emphasize transparency, accountability and independence, and believe this enhances shareholder value.

Our Board of Directors and management team are committed to principles of good corporate governance which are consistent with prudent management and enhancement of shareholder value. These principles emphasize transparency, accountability and independence.

Our Board of Directors comprises members with a broad range of experience and business and management skills across different industries.

These skill sets include supply chain management, banking and finance, talent management, leadership, risk management, global business and marketing. The Board is currently comprised of one Executive Director and seven Non-executive Directors.

  • Dr Victor Fung: Chairman and Non-executive Director, Chairman of Nomination and Remuneration Committees
  • Dr William FungNon-executive Director
  • Ben Chang: Group CEO and Executive Director
  • Martin Angus: Non-executive Director, Chairman of Audit Committee
  • Monica Tsui: Non-executive Director, Member of Audit, Nomination and Remuneration Committees
  • Tsui Lap Chee: Non-executive Director, Member of Nomination and Remuneration Committees
  • William Flanz: Non-executive Director
  • Henrik Pedersen: Non-executive Director, Member of Audit Committee

Board Committees 

The Board has established the following committees with defined terms of reference:

  • Audit Committee
  • Nomination Committee
  • Remuneration Committee

 

Audit Committee

The Audit Committee was established in 2017 to review the Group’s financial reporting, internal controls and corporate governance issues and make relevant recommendations to the Board.

The Committee is chaired by a Non-executive Director and all Committee members are Non-executive Directors. The Committee includes members with appropriate accounting or related financial management expertise.

 

Nomination Committee

The Nomination Committee was established in 2017 and is chaired by a Non-executive Director. Its terms of reference cover recommendations to the Board on the appointment of Directors, evaluation of Board composition, assessment of the independence of Independent Non-executive Directors, the management of Board succession, identification of suitably qualified individuals to become Board members, selecting or making recommendations to the Board on the selection of individuals nominated for directorships, and monitoring the training and continuous professional development of Directors and senior management.

 

Remuneration Committee

The Remuneration Committee was established in 2017 and is chaired by a Non-executive Director. The Committee’s responsibilities as set out in its terms of reference include making recommendations to the Board for approval on the remuneration policy for all Directors and senior management, including the granting of share options and award shares to employees and determining the remuneration packages of individual Executive Directors and senior management.


©idsMED 2018